HEALTHJul 7 · 16:44 UTCSTAT NEWSAdam Feuerstein

STAT+: FDA approves Vera Therapeutics kidney disease treatment

The FDA approved Trutakna, a new treatment for IgA nephropathy, a chronic autoimmune kidney disease, developed by Vera Therapeutics. Vera CEO Marshall Fordyce expressed excitement about bringing the drug to patients.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

FDAorganizationVera TherapeuticsorganizationTrutaknatopicIgA nephropathytopicMarshall Fordyceperson

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 12 · 22:00 UTC
New option available for Alzheimer’s patients as FDA approves expanded drug use
HEALTHJul 1 · 11:38 UTC
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
HEALTHMay 18 · 17:05 UTC
STAT+: AstraZeneca picks up FDA approval for hypertension drug
HEALTHMay 14 · 14:14 UTC
STAT+: BeOne wins FDA approval in lymphoma race